Clinical Value of Abnormal Prothrombin Combined with CEA, CA72-4 and CA199 on Patients with Gastric Cancer

Clinical Value of Abnormal Prothrombin Combined with CEA, CA72-4 and CA199 on Patients with Gastric Cancer

Objective To evaluate the clinical value of abnormal prothrombin (PIVKA-Ⅱ) combined with CEA, CA199 and CA72-4 on the diagnosis, treatment, recurrence and metastasis of patients with gastric cancer. Methods Serum PIVKA-Ⅱ, CEA, CA72-4, CA199 levels in 123 gastric cancer patients, 80 healthy controls...

Full description

Bibliographic Details
Main Authors: CAI Xiaojuan, WANG Kun, YU Jing
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2018-06-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
abnormal prothrombin
tumor markers
gastric cancer
diagnosis
monitor
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2018.17.1007.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2018.17.1007.htm

Similar Items